CF PharmTech, a Chinese pharma company, has raised $50 million in a Series F financing round to accelerate the commercialization of its inhalation products. The investors who took part in…
The Carlyle Group has signed a deal worth around $490 million with Piramal Enterprises, to acquire a stake of 20% from the Indian conglomerate’s pharma business – Piramal Pharma. The…
Covid-19 stem cell clinical trial : Celltex Therapeutics has been given the clearance by the US Food and Drug Administration (FDA) to move ahead with a phase 2 clinical trial…
Masimo, a US medical device company, has received clearance from the US Food and Drug Administration (FDA) for Centroid, the company’s wearable, wireless patient orientation, activity, and respiration rate sensor.…
Bristol Myers Squibb and Acceleron Pharma have secured approval from the European Commission (EC) for their jointly developed erythroid maturation agent Reblozyl (luspatercept) for the treatment of transfusion-dependent anemia in…
Massachusetts-based Yumanity Therapeutics has secured a drug development deal worth up to nearly $500 million with pharma giant Merck to develop new therapies for neurodegenerative disorders. The partnership is set…
Masimo gets FDA clearance for Centroid patient monitoring sensor
Masimo, a US medical device company, has received clearance from the US Food and Drug Administration (FDA) for Centroid, the company’s wearable, wireless patient orientation, activity, and respiration…
Roche gets FDA nod for cobas EZH2 Mutation Test as companion diagnostic for follicular lymphoma patients
Roche has secured approval from the US Food and Drug Administration (FDA) for its cobas EZH2 Mutation Test as a companion diagnostic for TAZVERIK (tazemetostat), developed by Epizyme.…
Medtronic secures $337m from Blackstone to develop diabetes technologies
Irish medical device company Medtronic has secured a $337 million product investment from Blackstone Life Sciences for advancing new, innovative products particularly designed to ease the burden of diabetes…
RapidAI acquires aneurysm management platform developer EndoVantage
RapidAI, an AI-based medical imaging company, has acquired EndoVantage, the developer of the Find, Track and Treat cerebral aneurysm management platform for an undisclosed price. Through the acquisition,…
China’s CF PharmTech raises $50m in Series F round for inhalation products
CF PharmTech, a Chinese pharma company, has raised $50 million in a Series F financing…
India-based Piramal Pharma secures $490m investment from Carlyle Group
The Carlyle Group has signed a deal worth around $490 million with Piramal Enterprises, to…
EC approves Reblozyl for transfusion-dependent anemia in adults
Bristol Myers Squibb and Acceleron Pharma have secured approval from the European Commission (EC) for…
Yumanity secures $500m worth deal with Merck to develop therapies for neurodegenerative disorders
Massachusetts-based Yumanity Therapeutics has secured a drug development deal worth up to nearly $500 million…
Gilead to acquire stake in cancer immunotherapy company Pionyr Immunotherapeutics
Gilead Sciences has agreed to acquire a stake of 49.9% in California-based cancer immunotherapy company…
Piramal Pharma acquires solid oral dosage drug product facility in Sellersville
Piramal Pharma Solutions has agreed to acquire the solid oral dosage drug product manufacturing facility…
Merck completes acquisition of Austrian vaccine developer Themis Bioscience
Pharma giant Merck has wrapped up its previously announced acquisition of Austrian vaccine developer Themis…
Latest Pharma News
-
China’s CF PharmTech raises $50m in Series F round for inhalation products
-
India-based Piramal Pharma secures $490m investment from Carlyle Group
-
Celltex Therapeutics gets FDA nod for Covid-19 stem cell clinical trial
-
Masimo gets FDA clearance for Centroid patient monitoring sensor
-
EC approves Reblozyl for transfusion-dependent anemia in adults
-
Yumanity secures $500m worth deal with Merck to develop therapies for neurodegenerative disorders
-
Zogenix bags Fintepla FDA approval for Dravet syndrome treatment
-
Gilead to acquire stake in cancer immunotherapy company Pionyr Immunotherapeutics
-
Imperial College begins human trial of coronavirus vaccine candidate COVAC1
-
Reneo Pharmaceuticals gets FDA ODD for REN001 in primary mitochondrial myopathies
Health Blog
-
Nestlé to acquire majority stake in US collagen brand Vital Proteins
-
Victory Nutrition launches PerformLyte electrolyte, phytonutrient formula
-
Bonne Santé Natural Immunology nutraceutical products launched
-
Consumption of berry juice helps in lowering blood pressure
-
Children consuming whole milk can reduce risk of overweight
